LEXARIA BIOSCIENCE CORP. Equity Securities, FV-NI, Unrealized Gain (Loss)
LEXARIA BIOSCIENCE CORP. (LEXX) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of -$22.09 thousand for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2026-05-31 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-05-31 was $4.16K.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 6 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month |
|---|---|---|---|
| 2026-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13 | -$22.09K 10-Q · filed 2026-07-13 | |
| 2026-02-28 | -$22.09K 10-Q · filed 2026-04-13 | ||
| 2025-05-31 | $4.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13 | $22.27K 10-Q · filed 2026-07-13 | |
| 2025-02-28 | $18.11K 10-Q · filed 2026-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |